3-Methoxycarbonyl-4-chlorophenylisothiocyanate, 98.0%, 1g

2-((2R,3R)-3-(tert-butyl)-4-methoxy-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 95%,99%ee, 500mg

4-amino-N-(furan-2-ylmethyl)-3-methylbenzamide, 95.0%, 1g

4-formyl-N,N-dimethylbenzenesulfonamide, 95.0%, 250mg

Plan de larga distancia de trabajo fase 40x/0,65 Objetivo IOS, distancia de trabajo 2,74 mm

3,4,8-trimethyl-7-(1-methyl-2-oxopropoxy)-2H-chromen-2-one, 95.0%, 5g

(R)-2-Amino-2-(4-bromophenyl)acetic acid, 95+%, 5g

2-(Benzyloxy)-5-bromo-3-methylbenzaldehyde, 95%, 500mg

3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-imidazo[4,5-b]pyridine, 95.0%, 10g

Methyl 6-methoxy-2-naphthoate, 98%, 1g

Sodium 2-mercaptoethanesulfonate, 97.0%, 100g

1-(3,5-Dibromophenyl)ethanone, 95.0%, 10g

4-Acetoxybenzaldehyde, 98.0%, 5g